Navigation Links
Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Date:6/12/2008

ck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Such forward-looking statements include statements about the results of the Phase 2a clinical trial of APD125; the continued development and evaluation of APD125; the protocol, design, scope and other aspects of clinical trials of APD125; the tolerability, side effects, safety profile, efficacy, mechanism of action and the commercial and other potential of APD125 and other of Arena's drug candidates; the possibility of APD125 to be a non-scheduled treatment; the relevance of indicators of sleep maintenance; Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to partner lorcaserin, APD125, APD791 or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents, the timing and receipt of payments and fees, if any, from Arena's collaborators, and Arena's ability to redeem with common stock any outstanding shares of its series B convertible preferred stock. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are d
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
2. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
4. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
5. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
7. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
10. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... /PRNewswire-iReach/ -- The escalation of new biological drugs, ... emphasis on alternate delivery technologies. Alternate delivery technologies ... factors are converging to create both risk ... device partners . These include new classes of ... toward self-administration for chronic diseases, shifting patient demographics ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
(Date:5/16/2013)... SINGAPORE and ZURICH , May ... Agency for Science, Technology and Research (A*STAR) and ... the first healthy volunteer has been dosed in a Phase ... on Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In ... of this novel vaccine candidate and its potential to protect ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... 11, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... announced 1-for-20 reverse split of its common stock will ... March 14, 2011. Nephros common stock will be quoted ...
... March 11, 2011 Ferring Pharmaceuticals Inc. congratulates ... receive the inaugural Woman of the Year award ... part of the Foundation,s arthritis awareness initiative, Women ... her formidable personal and professional accomplishments despite being ...
Cached Medicine Technology:Nephros Announces Completion of Reverse Stock Split 2Nephros Announces Completion of Reverse Stock Split 3Nephros Announces Completion of Reverse Stock Split 4Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named 'Woman of the Year' by Arthritis Foundation 2Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named 'Woman of the Year' by Arthritis Foundation 3
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... they have filed a diving accident lawsuit on ... of a tragic dive into shallow water. The diving accident ... State New York, Suffolk County, alleges the Defendant held the ... warnings or signs against diving in the area. (Case No. ...
(Date:5/19/2013)... CO (PRWEB) May 19, 2013 Daily Gossip ... guide 17 Cheat Foods That Burn Fat to ... its readers. , The review is a ... followed by the writer's recommendation. , The two nutritionists have ... that is responsible for the caloric intake and expenditure of ...
(Date:5/19/2013)... May 19 (HealthDay News) -- Although spring arrived late ... summer allergy season will still be strong, according to ... Birmingham. Dr. Richard Waguespack, clinical professor in the ... results in a robust summer allergy season. However, some ... sneezing, wheezing and coughing, he added. "Tree pollen ...
(Date:5/19/2013)... Healthcare leaders will gather at the ... Walt Disney World Swan and Dolphin in Orlando, Fla., ... care delivery and healthcare reform and implementation. , “Reform ... markets, with consolidation, efficiency and reduced payments ... Ebert, Amerinet president and CEO. “There is a real ...
(Date:5/19/2013)... 2013 Actos lawsuit claims ... underway in U.S. District Court, Western District of Louisiana. ... 3rd, the Court has modified the litigation’s Bellwether Nomination ... rather than four. The next Status Conference in the ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
Breaking Medicine News(10 mins):Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Managing Seasonal Allergies 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3
... Nutrition research is pointing to ways that nutrients or ... (TBI), raising the possibility that the U.S. Department of ... help personnel who receive a TBI. Nutrition ... Outcomes in Military Personnel, a new report from the ...
... to sleep on his bunk bed one night and never woke ... with his neck caught between the vertical post of his side ... to have strangled in the space between a bunk bed ladder ... Consumer Product Safety Commission (CPSC). In the Forensic Ergonomics Special Issue ...
... School of Medicine and Kent State University shows that ... harder for the cardiovascular system to simultaneously juggle the ... For decades, medical researchers have sought to understand how ... Some individuals, described as "salt sensitive," experience an increase ...
... lack of sleep and strange surroundings can make any ... seniors, hospitalizations actually may cause temporary memory loss and ... Northwestern Medicine study. The seniors go back ... study found. But immediately following a hospitalization is a ...
... News) -- Parents who say "um" and "uh" when speaking ... helping the children learn language more efficiently, according to researchers. ... found that older children paid more attention to an image ... stumbled and said, "Look at the, uh..." When a ...
... polluted air appears to activate a protein that triggers ... that lead to widespread inflammation, according to new research ... gap in researchers, understanding of how prolonged exposure to ... other diseases. The research group, led by Ohio ...
Cached Medicine News:Health News:Human Factors/Ergonomics research leads to improved bunk bed safety standards 2Health News:New study identifies possible cause of salt-induced hypertension 2Health News:New study identifies possible cause of salt-induced hypertension 3Health News:Temporary memory loss strikes hospitalized seniors 2Health News:Polluted air leads to disease by promoting widespread inflammation 2Health News:Polluted air leads to disease by promoting widespread inflammation 3Health News:Polluted air leads to disease by promoting widespread inflammation 4Health News:Polluted air leads to disease by promoting widespread inflammation 5
... Image Processing Video Camera is our new ... ACMI Image Processing (IP) technology, the IP ... detail. Exciting new features, enhanced image quality, ... an exceptional value. All IP 4.2 cameras ...
... Xenon, Metal Halide and Halogen illumination systems ... design. In addition, Olympus provides the highest ... in conjunction with a lightweight, durable design., ... system, but compatible with all surgical endoscopic ...
... VIBROLITH is an intracorporeal electrokinetic lithotripter ... stones. VIBROLITH guarantees satisfaction in application ... bladder, gall bladder and salivary gland ... in percutaneous applications. Kinetic energy transmitted ...
... Medical Solutions is a comprehensive modular solution ... Urodiagnostics, endourology, lithotripsy, prostate diagnostics and therapy, ... of a urologists responsibilities on a given ... supports the various diagnostic or therapeutic applications, ...
Medicine Products: